India’s approval of own COVID vaccine criticised for lack of data

Read MoreOpposition politicians and former ministers warn approval may be premature and risky after government fast-tracks Covaxin.Opposition politicians and former ministers warn approval may be premature and risky after government fast-tracks Covaxin.